Marker Therapeutics, Inc. (MRKR)

1.39 -0.05 (-3.47%) USD  |  NASDAQ  |  Mar 05, 16:00
1.40 +0.01 (+0.72%) Pre-Market: 20:00
More

Marker Therapeutics Net Income Per Employee (Annual)

Net Income Per Employee (Annual) Chart

View Net Income Per Employee (Annual) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income Per Employee (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income Per Employee (Annual) Range, Past 5 Years

View Net Income Per Employee (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income Per Employee (Annual) Benchmarks

View Net Income Per Employee (Annual) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade